Home
|
Inbox
|
Search
|
Speaker
Jean Claude. Tardif
MD, Ph.D.
Institut de Cardiologie de Montreal
Session(s)
- PBI-4050, a Novel First-in-Class Agent, Improves Hypoxia/Sugen Induced Pulmonary Arterial ...
Monday, May 21 2:15 PM - 4:15 PM - PBI-4050, a Novel First-in-Class Antifibrotic Agent, Improves Pulmonary Hypertension and F...
Monday, May 21 2:15 PM - 4:15 PM - PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ve...
Monday, May 21 2:15 PM - 4:15 PM
|
Home
|
Inbox
|
Search
|